Literature DB >> 10428274

Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism.

S Natori1, M Selzner, K L Valentino, L C Fritz, A Srinivasan, P A Clavien, G J Gores.   

Abstract

BACKGROUND: Cold ischemia/warm reperfusion (CI/WR) liver injury remains a problem in liver transplants. Sinusoidal endothelial cells (SEC) are a target of CI/WR injury, during which they undergo apoptosis. Because caspase proteases have been implicated in apoptosis, our aim was to determine whether liver CI/WR injury induces a caspase-dependent apoptosis of SEC.
METHODS: Rat livers were stored in the University of Wisconsin (UW) solution for 24 hr at 4 degrees C and reperfused for 1 hr at 37 degrees C in vitro. Apoptosis was quantitated using the TUNEL assay, and caspase 3 activation determined by immunohistochemical analysis. Rat liver orthotopic liver transplants (OLT) were also performed using livers stored for 30 hr.
RESULTS: Terminal deoxynucleotide transferase-mediated dUTP nick end labeling (TUNEL) positive hepatocytes were rare and did not increase during CI/WR injury. In contrast, TUNEL positive SEC increased 6-fold after reperfusion of livers stored under cold ischemic conditions, compared with controls or livers stored but not reperfused. Immunohistochemical analysis demonstrated active caspase 3 only in endothelial cells after CI/WR injury. When IDN-1965, a caspase inhibitor, was given i.v. to the donor animal and added to UW solution and the reperfusion media, TUNEL positive endothelial cells were reduced 63+/-11% (P<0.05). Similarly, the duration of survival after OLT was significantly increased in the presence of the inhibitor.
CONCLUSION: During liver CI/WR injury: 1) selective apoptosis of endothelial cells occurs; 2) caspase 3 is activated only in endothelial cells; and 3) a caspase inhibitor reduces endothelial cell apoptosis and prolongs animal survival after OLT. The pharmacologic use of caspase inhibitors could prove useful in clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428274     DOI: 10.1097/00007890-199907150-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  50 in total

Review 1.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

2.  Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Fernando J Barreyro; Maria E Guicciardi; Yuko Akazawa; Karen Braley; Ruth W Craig; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

3.  Effect of emodin in suppressing acute rejection following liver allograft transplantation in rats.

Authors:  Sheng-zhang Lin; Hong-fei Tong; Kang-jie Chen; He Jing; Xiao Yang; Shu-sen Zheng
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

4.  Inhibition of Caspase-1 Activation in Endothelial Cells Improves Angiogenesis: A NOVEL THERAPEUTIC POTENTIAL FOR ISCHEMIA.

Authors:  Jahaira Lopez-Pastrana; Lucas M Ferrer; Ya-Feng Li; Xinyu Xiong; Hang Xi; Ramon Cueto; Jun Nelson; Xiaojin Sha; Xinyuan Li; Ann L Cannella; Princess I Imoukhuede; Xuebin Qin; Eric T Choi; Hong Wang; Xiao-Feng Yang
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

5.  Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver.

Authors:  Hannes A Rüdiger; Koo J Kang; David Sindram; Hans M Riehle; Pierre A Clavien
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

Review 6.  New insights into host-pathogen interactions during Entamoeba histolytica liver infection.

Authors:  D M Faust; J Marquay Markiewicz; J Santi-Rocca; N Guillen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

Review 7.  Caspase inhibitors for the treatment of hepatitis C.

Authors:  Howard C Masuoka; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Clin Liver Dis       Date:  2009-08       Impact factor: 6.126

8.  Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury.

Authors:  Kee-Hwan Kim; Rajeev Dhupar; Shinya Ueki; Jon Cardinal; Pinhua Pan; Zongxian Cao; Sung W Cho; Noriko Murase; Allan Tsung; David A Geller
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

9.  Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Steven F Bronk; Sophie Cazanave; Nathan W Werneburg; Justin L Mott; Patricia C Contreras; Gregory J Gores
Journal:  Hepatol Res       Date:  2009-07-13       Impact factor: 4.288

Review 10.  Factors in the pathophysiology of the liver ischemia-reperfusion injury.

Authors:  Eduardo E Montalvo-Jave; Tomas Escalante-Tattersfield; Jose A Ortega-Salgado; Enrique Piña; David A Geller
Journal:  J Surg Res       Date:  2007-07-27       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.